Project Grant HT94252410934

Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $1.7M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $713,277 to Boston University Medical Campus to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The award will support the project from September 1, 2024 through August 31, 2027. As part of this...
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
The Department of the Army Medical Command awarded Boston University $999,636 under the Military Medical Research and Development federal grant program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The award will support the identification of objective brain imaging biomarkers for Gulf War Illness through exposure- and symptom-specific markers, Gulf War illness subtypes, and longitudinal patterns. Dr. Steele of Baylor College of Medicine will collaborate with Boston University researchers on...
The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
The Department of the Army Medical Command awarded a $1.85 million Project Grant to Texas A&M University System Health Science Center to support research probing neuroinflammation in Gulf War illness via studies on Gulf War veteran-derived microglia. The grant was awarded on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 29, 2025. As part of the award, $150,000 in sub-award funding was provided to Drexel...
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
This $1,224,089 Department of Defense Project Grant awarded on September 30, 2023 to Texas A&M University System Health Science Center will fund a 3-year research project titled "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI". The project will be conducted under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research to transform healthcare for Service...
The Defense Health Agency awarded a $781,300.00 Project Grant titled "RELATIONSHIP OF METAL EXPOSURES TO HEALTH RISK MARKERS, MOOD, AND COGNITIVE FUNCTIONING IN MILITARY VETERANS" to Trustees of Boston University Medical Campus. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate the relationship between metal exposures, health risk indicators, mood, and cognitive functioning in military veterans. Dartmouth...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...

This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August 31, 2027. The research aims to investigate how genetic factors and environmental exposures interact to influence neurological health over time, with the goal of improving understanding and treatment of GWI and related conditions impacting military personnel and veterans.

Generated 5/13/25, 1:45 AM